Send to

Choose Destination
See comment in PubMed Commons below
Regul Pept. 1996 Sep 9;65(2):101-7.

Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets.

Author information

  • 1Department of Medicine, Lund University, Malmö University Hospital, Sweden.


Cholecystokinin (CCK) has been shown to stimulate insulin secretion through an effect which involves mediation by phospholipase C (PLC) and protein kinase C (PKC). However, data exist suggesting involvement also of other transduction pathways. We investigated possible involvement of phospholipase A2 (PLA2) and arachidonic acid (AA) in mechanisms of insulin secretion, induced by the C-terminal octapeptide of CCK (CCK-8) in isolated rat islets. At 5.6 mM glucose, the specific PLA2 inhibitor p-amylcinnamoylantranilic acid (ACA; 50 microM) diminished CCK-8 (100 nM)-stimulated insulin secretion (by 57 +/- 16%; P = 0.001). Furthermore, at 5.6 mM glucose, CCK-8 significantly increased the efflux of [3H]arachidonic acid from prelabelled islets (by 130 +/- 25%; P < 0.001). These results imply that CCK-8 activates PLA2 to form AA in islets. To study whether the insulinotropic effect of CCK-8 is due to AA per se or to its metabolites, the oxidative pathways of the AA metabolism were inhibited. However, the cyclooxygenase inhibitors, indomethacin (30 microM) and salicylate (1.25 mM) as well as the lipoxygenase inhibitors baicalein (1-100 microM) and esculetin (0.5-50 microM), did not affect CCK-8-induced insulin secretion. We conclude that CCK-8-induced insulin secretion is partially mediated by a pathway involving PLA2, and that the formed AA, rather than its metabolites, is of importance.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk